
DMAT
PUBLIC LIMITED
Price Chart
High
₹6,090
Low
₹5,800
Return
5.00%
ISIN
INE316F01011
Face Value
10
Total Shares
11,47,67,049
Market Cap
69,893.13 Cr
Profit After Tax
2,422.77 Cr
Total Revenue
19,882.83 Cr
P/E
28.85
P/B
4.38
Sector
Health Care
Sub-sector
Pharmaceuticals
Category
Mid Cap
Cashflow - Operations
3,284.12 Cr
Company Overview:
Explore in-depth financial analysis, performance metrics, and key disclosures.
News
Articles
Videos
Intas & Accord Expand Global Pegfilgrastim Reach with UDENYCA Acquisition
07 Aug 2025
• Express pharma
Intas Pharmaceuticals Launches Hetronifly™, India’s First Novel Immunotherapy for Small Cell Lung Cancer
04 Aug 2025
• PR Newswire
Biosimilar brand buy to help Intas Pharma take on biggies
05 Feb 2025
• Economic Times
Mutual Fund License No.:
ARN-164419
IRDA Code (1):
ABLIC1003123454
IRDA Code (2):
ABLIC1003131639
Startup India Certificate No.:
DIPP93786
Other Websites
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India
MiQB, Plot 23, Sector 18, Maruti Industrial Development Area, Opposite VLCC corporate office, Gurugram, Haryana 122015
Mutual Fund License No.
ARN-164419
IRDA Code (1):
ABLIC1003123454
Startup India Certificate No.
DIPP93786
IRDA Code (2):
ABLIC1003131639
Licensed By
Stay Connected With Us
through our iOS and Android apps for an on-the-go investing experience. Download our apps today App Store or Google Play Store.
ⓒ 2016-2026 Planify. All rights reserved, Built with ❤️ in India